Home > Press > Selah Joins EPA Nanomaterials Stewardship Program: Selah to Participate in the In-Depth Program
Abstract:
Selah Technologies announced today that the company has committed to join the In-Depth portion of the Nanoscale Materials Stewardship Program (NMSP) administered by the U.S. Environmental Protection Agency (EPA). The EPA's NMSP was developed to provide a firmer scientific foundation for regulatory policy decisions by encouraging submission and development of information for nanoscale materials.
"Selah is eager to help the EPA better understand the environmental impact of our carbon-based quantum dots," said Michael Bolick, President and CEO of Selah Technologies. "Joining the NMSP and offering our assistance and contribution is the right thing to do. We look forward to collaborating with the EPA on the In-Depth Program and welcome additional collaborations with companies who share our interest in the product stewardship of carbon-based nanomaterials," continued Bolick.
The NMSP is comprised of two components - a Basic Program and an In-Depth Program. The Basic Program was designed to encourage the submission of available data on nanoscale materials and thus far 29 companies and trade associations have provided information on 123 nanoscale materials. The In-Depth Program provides a way for participants to work with the EPA to identify where additional information may be useful in regulatory decision making and to identify ways to generate this information. Selah is pleased to be one of the first companies to participate in the more comprehensive In-Depth Program.
Selah Technologies obtained a worldwide exclusive license in 2006 from Clemson University to develop and commercialize two nanotechnologies. Selah Dots™ are patent-pending brightly luminescent carbon-based nanoparticles designed to be used as bio-imaging agents, replacing fluorescent dyes, microbeads and heavy metal-based quantum dots. Selah Tubes™, enriched carbon nanotubes protected under US Patent No. 7,374,685, have a number of applications due to their impressive electrical conductivity properties.
####
About Selah Technologies
Founded in 2006, Selah Technologies is a privately held advanced materials innovator focused on the development of nanotechnology-enabled products for the biomedical industry.
For more information, please click here
Contacts:
Selah Technologies, LLC
Michael Bolick
864-646-5888, ext. 111
Copyright © Business Wire 2009
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Govt.-Legislation/Regulation/Funding/Policy
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Single atoms show their true color July 5th, 2024
Nanotubes/Buckyballs/Fullerenes/Nanorods/Nanostrings
Tests find no free-standing nanotubes released from tire tread wear September 8th, 2023
Detection of bacteria and viruses with fluorescent nanotubes July 21st, 2023
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Safety-Nanoparticles/Risk management
Tests find no free-standing nanotubes released from tire tread wear September 8th, 2023
Billions of nanoplastics released when microwaving baby food containers: Exposure to plastic particles kills up to 75% of cultured kidney cells July 21st, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||